MediPal Holdings Corporation
7459.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | ¥3,671 | ¥3,559 | ¥3,360 | ¥3,291 |
| % Growth | 3.2% | 5.9% | 2.1% | – |
| Cost of Goods Sold | ¥3,429 | ¥3,312 | ¥3,136 | ¥3,073 |
| Gross Profit | ¥242 | ¥247 | ¥224 | ¥217 |
| % Margin | 6.6% | 6.9% | 6.7% | 6.6% |
| R&D Expenses | ¥0 | ¥1 | ¥0 | ¥0 |
| G&A Expenses | ¥0 | ¥164 | ¥144 | ¥141 |
| SG&A Expenses | ¥24 | ¥185 | ¥163 | ¥159 |
| Sales & Mktg Exp. | ¥24 | ¥20 | ¥19 | ¥19 |
| Other Operating Expenses | ¥163 | ¥14 | ¥12 | ¥12 |
| Operating Expenses | ¥187 | ¥199 | ¥175 | ¥172 |
| Operating Income | ¥56 | ¥47 | ¥49 | ¥46 |
| % Margin | 1.5% | 1.3% | 1.5% | 1.4% |
| Other Income/Exp. Net | ¥21 | ¥27 | ¥21 | ¥12 |
| Pre-Tax Income | ¥77 | ¥75 | ¥70 | ¥57 |
| Tax Expense | ¥25 | ¥23 | ¥22 | ¥18 |
| Net Income | ¥40 | ¥41 | ¥39 | ¥29 |
| % Margin | 1.1% | 1.2% | 1.2% | 0.9% |
| EPS | 193.19 | 195.83 | 184.82 | 140.13 |
| % Growth | -1.3% | 6% | 31.9% | – |
| EPS Diluted | 193.19 | 195.83 | 179.12 | 131.41 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | ¥0 | ¥0 | ¥0 | ¥0 |
| Interest Expense | ¥0 | ¥0 | ¥0 | ¥0 |
| Depreciation & Amortization | ¥18 | ¥18 | ¥15 | ¥14 |
| EBITDA | ¥95 | ¥93 | ¥85 | ¥72 |
| % Margin | 2.6% | 2.6% | 2.5% | 2.2% |